Literature DB >> 1330375

Concentration of serum laminin and type IV collagen in liver diseases assayed by a sandwich enzyme-immunoassay using monoclonal antibodies.

Y Yokoya1, K Iwata, Y Muragaki, C Shiota, Y Morimoto, M Inoue, H Itoh, S Nishioka, A Ooshima.   

Abstract

Serum laminin (P1 fragment) and type IV collagen levels were determined in patients with hepatic disorders. The method was based on a sandwich enzyme-immunoassay using two monoclonal antibodies that recognize different epitopes of either laminin or type IV collagen molecule. Laminin and type IV collagen levels in the serum of patients with chronic hepatic disorders were higher as compared with those in healthy control subjects, with the increment of serum type IV collagen being far greater than that of laminin. Since type IV collagen and laminin are major basement membrane components, it is suggested that the higher levels of these peptides may reflect a so-called capillarization of the perisinusoidal wall encountered in hepatic fibrogenesis. The assay system used in this experiment is simple and sensitive and can be applied to clinical evaluation of hepatic fibrosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1330375     DOI: 10.1016/0009-8981(92)90049-v

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  3 in total

1.  Serum laminin and basic fibroblast growth factor concentrations in patients with complicated Plasmodium falciparum malaria.

Authors:  H Burgmann; S Looareesuwan; C Viravan; S Vanijanonta; K Zedwitz-Liebenstein; H Vorbach; W Graninger
Journal:  J Clin Immunol       Date:  1996-09       Impact factor: 8.317

2.  Improved tumour marker sensitivity in detecting colorectal liver metastases by combined type IV collagen and CEA measurement.

Authors:  Hanna Nyström; Björn Tavelin; Moa Björklund; Peter Naredi; Malin Sund
Journal:  Tumour Biol       Date:  2015-07-11

3.  Clinical Benefits of Biochemical Markers of Fibrosis in Egyptian Children With Chronic Liver Diseases.

Authors:  Tawhida Y Abdel-Ghaffar; Behairy E Behairy; Azza Abd El-Shaheed; Karam Mahdy; Mohamed El-Batanony; Mohsen H Hussein; Mostafa M Sira
Journal:  Gastroenterology Res       Date:  2010-11-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.